Laboratorio Reig Jofre S.A (RJF) - Total Assets

Latest as of September 2025: €355.15 Million EUR ≈ $415.21 Million USD

Based on the latest financial reports, Laboratorio Reig Jofre S.A (RJF) holds total assets worth €355.15 Million EUR (≈ $415.21 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Laboratorio Reig Jofre S.A service its debt to assess how comfortably operating cash covers total debt obligations.

Laboratorio Reig Jofre S.A - Total Assets Trend (2004–2024)

This chart illustrates how Laboratorio Reig Jofre S.A's total assets have evolved over time, based on quarterly financial data. See what is Laboratorio Reig Jofre S.A's book value for net asset value and shareholders' equity analysis.

Laboratorio Reig Jofre S.A - Asset Composition Analysis

Current Asset Composition (December 2024)

Laboratorio Reig Jofre S.A's total assets of €355.15 Million consist of 43.4% current assets and 56.6% non-current assets.

Asset Category	Amount (EUR)	% of Total Assets
Cash & Equivalents	€0.00	3.0%
Accounts Receivable	€62.18 Million	18.0%
Inventory	€63.77 Million	18.5%
Property, Plant & Equipment	€0.00	0.0%
Intangible Assets	€55.28 Million	16.0%
Goodwill	€26.81 Million	7.8%

Asset Composition Trend (2004–2024)

This chart illustrates how Laboratorio Reig Jofre S.A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see RJF market cap.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Laboratorio Reig Jofre S.A's current assets represent 43.4% of total assets in 2024, a decrease from 49.3% in 2004.
Cash Position: Cash and equivalents constituted 3.0% of total assets in 2024, down from 6.1% in 2004.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, an increase from 12.0% in 2004.
Asset Diversification: The largest asset category is inventory at 18.5% of total assets.

Laboratorio Reig Jofre S.A Competitors by Total Assets

Key competitors of Laboratorio Reig Jofre S.A based on total assets are shown below.

Company	Country	Total Assets
Suven Pharmaceuticals Limited NSE:SUVENPHAR	India	Rs30.32 Billion
Neuland Laboratories Limited NSE:NEULANDLAB	India	Rs29.30 Billion
Bausch Health Companies Inc TO:BHC	Canada	CA$24.50 Billion
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	China	CN¥17.84 Billion
Changzhou Qianhong Biopharma Co Ltd SHE:002550	China	CN¥3.23 Billion
Cronos Group Inc TO:CRON	Canada	CA$1.18 Billion
Shandong Lukang Pharmaceutical Co Ltd SHG:600789	China	CN¥9.88 Billion
Heilongjiang ZBD Pharmaceutical Co Ltd SHG:603567	China	CN¥11.80 Billion

Laboratorio Reig Jofre S.A - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.85	1.83	1.33
Quick Ratio	0.99	1.00	0.79
Cash Ratio	0.00	0.00	0.00
Working Capital	€70.75 Million	€67.02 Million	€25.16 Million

Laboratorio Reig Jofre S.A - Advanced Valuation Insights

This section examines the relationship between Laboratorio Reig Jofre S.A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.03
Latest Market Cap to Assets Ratio	0.64
Asset Growth Rate (YoY)	4.3%
Total Assets	€344.85 Million
Market Capitalization	$221.39 Million USD

Valuation Analysis

Below Book Valuation: The market values Laboratorio Reig Jofre S.A's assets below their book value (0.64x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Laboratorio Reig Jofre S.A's assets grew by 4.3% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Laboratorio Reig Jofre S.A (2004–2024)

The table below shows the annual total assets of Laboratorio Reig Jofre S.A from 2004 to 2024.

Year	Total Assets	Change
2024-12-31	€344.85 Million ≈ $403.17 Million	+4.33%
2023-12-31	€330.55 Million ≈ $386.45 Million	+2.91%
2022-12-31	€321.19 Million ≈ $375.51 Million	-1.16%
2021-12-31	€324.98 Million ≈ $379.93 Million	+2.47%
2020-12-31	€317.15 Million ≈ $370.78 Million	+1.13%
2019-12-31	€313.62 Million ≈ $366.65 Million	+42.76%
2018-12-31	€219.68 Million ≈ $256.82 Million	+8.03%
2017-12-31	€203.34 Million ≈ $237.72 Million	-1.12%
2016-12-31	€205.63 Million ≈ $240.41 Million	+9.93%
2015-12-31	€187.05 Million ≈ $218.69 Million	+3.49%
2014-12-31	€180.74 Million ≈ $211.31 Million	+106.78%
2014-09-30	€87.41 Million ≈ $102.19 Million	+4.35%
2013-12-31	€83.77 Million ≈ $97.93 Million	-14.58%
2012-12-31	€98.06 Million ≈ $114.64 Million	-40.71%
2011-12-31	€165.38 Million ≈ $193.34 Million	-9.67%
2010-12-31	€183.09 Million ≈ $214.05 Million	-8.54%
2009-12-31	€200.18 Million ≈ $234.03 Million	-34.90%
2008-12-31	€307.50 Million ≈ $359.50 Million	-3.17%
2007-12-31	€317.55 Million ≈ $371.25 Million	+9.89%
2006-12-31	€288.98 Million ≈ $337.84 Million	+84.77%
2005-12-31	€156.40 Million ≈ $182.84 Million	+197.13%
2004-12-31	€52.64 Million ≈ $61.54 Million	--

About Laboratorio Reig Jofre S.A

MC:RJF Spain Drug Manufacturers - Specialty & Generic

Market Cap

$257.88 Million

€220.58 Million EUR

Market Cap Rank

#16182 Global

#104 in Spain

Share Price

€2.71

Change (1 day)

-1.45%

52-Week Range

€2.33 - €3.20

All Time High

€5.92